While the first patient underwent WES, which detected a pathogenic variant in COL4A5, the second patient had a nephrotic syndrome/focal segmental glomerulosclerosis sequencing panel that revealed a likely pathogenic variant in COL4A4. This evidence concerns the gene COL4A4 and focal segmental glomerulosclerosis.